MAPT and Alzheimer disease: The PLB1 mouse line is a triple transgenic model of AD containing hAPP with the London and Swedish mutations, human PS1 with an A246E mutation and human microtubule-associated protein tau (MAPT) P301L and R406W mutations (Bouter and Bouter, 2019).